Trials / Completed
CompletedNCT04309149
Market Research - Acceptability Study for a Range of MCT Products
Market Research - Acceptability Study for a Range of New MCT Based Products (Dr Schär - Kanso MCT) Kanso MCT 100% Oil Kanso MCT 77% Oil Kanso MCT 83% Margarine
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Dr. Schär AG / SPA · Industry
- Sex
- All
- Age
- 2 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children and young people with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MCT fats | Subjects will be asked to take 3 new MCT products for 7 days each over a 25 day period (21 days taking the new products with 2 days between each new product trialled). |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
- First posted
- 2020-03-16
- Last updated
- 2020-03-16
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04309149. Inclusion in this directory is not an endorsement.